Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Gansu Lanyao Pharmaceutical is a comprehensive pharmaceutical enterprise based in Lanzhou, China, with a history dating back to the establishment of the Lanzhou Pharmaceutical Factory in 1970. The company specializes in the research, development, and large-scale production of chemical raw materials (APIs) and finished dosage forms, including tablets, capsules, and injections. Its extensive product portfolio covers critical therapeutic areas such as anti-infectives, endocrinology, cardiovascular health, and neurology. Operating multiple GMP-certified production lines, the company serves as a major pharmaceutical manufacturing hub in Northwest China. Gansu Lanyao Pharmaceutical is recognized for its established generic brands and its capacity for high-volume chemical synthesis and pharmaceutical formulation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Gansu Lanyao Pharmaceutical.